INTRODUCTION
Gastrointestinal stromal tumors (GISTs) are submucosal tumors that are originated from the digestive tract organs such as esophagus, stomach, small intestine, colon and rectum. [1] GISTs are the most frequent mesenchymal tumors of the digestive tract which are originated from the interstitial Cajal cells localized on the intestinal wall and from neoplastic transformation of Cajal cell progenitors. [2] The most common localization of GISTs is the stomach (50%-60%), followed by the small intestines (20%-25%) and rectum (5%). [3, 4] Approximately 50% of the GISTs have already had distant metastasis when they are diagnosed, with the liver and peritoneum being the most common regions for metastasis. Surgical intervention is the main method for histopathological diagnosis of GISTs. The primary purpose of surgical treatment in surgically resectable GISTs is to perform a resection with clear surgical margins, leaving no visible tumor. In this case report, we aimed to investigate the diagnosis and treatment of ileal GIST detected in a patient who was admitted to our emergency department, diagnosed with mechanical intestinal obstruction due to small intestinal tumor after evaluation and got surgical intervention.
CASE REPORT
A 65-year-old male patient was admitted to the emergency department of our hospital with the complaints of abdominal pain, vomiting, inability to pass gas and no bowel movement. In the physical examination; abdominal distention, tenderness, and rebound were found. The white blood cell count was 19.9x10 3 /μL, hemoglobin 10.3 g/dL and hematocrit 32.8%. Abdomino-pelvic computed tomography (CT) showed air-fluid levels in the ileo-jejunal loops, and a mass lesion with soft tissue density, approximately 67x33 mm in size at the widest dimension and protruding in the lumen proximal to the ileal loops was identified (Fig. 1 ). The patient was operated with the diag-nosis of acute abdomen due to mechanical ileus which was made with the help of examination and workup results. Some dilatation in the proximal of small intestines was observed. A tumoral mass of approximately 9x4 cm with a hard consistency, protruding from the serosa, obstructing the lumen approximately 130 cm proximal to the ileocecal valve was detected, and total resection with clear surgical margins and side-to-side small intestinal anastomosis were performed ( Fig. 2 ). Pathological examination revealed GIST, tumor with a maximum diameter of 7.5 cm, had 10 mitosis in 50 high power fields and infiltrated into the mucosa. Surgical margins are clear. Immunohistochemical staining ratio was strongly diffuse positive for CD117 (c-Kit), DOG1, CD34, focal positive for SMA, and Ki-67 proliferation index was 6%-7%. Cystic lysis regions have been observed in the tumor and no necrosis was identified. The patient was discharged on the postoperative day 7 without any complications with Imatinib treatment plan.
DISCUSSION
GISTs are mesenchymal tumors originating from interstitial Cajal cells that can develop from the esophagus to the internal anal sphincter throughout the gastrointestinal tract, as well as from the omentum, genitourinary system, portal vein and pancreas (extra-GIST). [2] Although GISTs are generally seen after the age of 40, they occur most commonly in the 60s. [5] Our case was 65 years old and was in the age range reported in the literature. GIST is the most common mesenchymal tumor of the small intestines and covers 15% to 20% of all small intestinal tumors. [6, 7] When GISTs are studied in terms of the localization, it is mostly seen in the stomach (50%-60%), following with the small intestines (20%-25%), rectum (5%) and esophagus (2%) in decreasing frequency. [8] In our case, GIST was originated from the proximal ileum.
GISTs are usually asymptomatic when the tumor is <2 cm in diameter and are detected incidentally during a radiological imaging, endoscopic procedure, or surgical intervention done for another causes. GISTs that present with symptoms in patients may cause abdominal pain, dysphagia, dyspeptic complaints, digestive system bleeding, chronic anemia and abdominal mass according to the location of the tumor, but nonspecific to GIST. [9] They may also present with signs requiring urgent medical or surgical intervention, such as intra-abdominal bleeding, massive gastrointestinal bleeding, gastrointestinal perforation, or mechanical bowel obstruction. Our patient had acute abdomen due to mechanical bowel obstruction and urgent laparotomy was required. In our case, GIST was extramural and obstructed the small intestinal lumen due to its size. Differential diagnosis of these tumors in preoperative period is not easy. This is mainly due to the lack of specificity of the symptoms and diagnostic methods used in patients. In our case, the presence of a mass causing dilatation of proximal ileal loops on abdomino-pelvic CT, which was taken for diagnosis in emergency conditions, was effective in making the decision for surgical intervention. In GISTs with a tumor diameter >2 cm, complete resection by surgical intervention should be considered in the first place. Periodic follow-up can be performed in GISTs with tumor diameter <2 cm. Endoscopic resection of GISTs in the stomach has been described in the literature, but the difficulties in obtaining a negative resection margin have not been sufficiently sought due to the risk of perforation in the stomach and the spread of the tumor after endoscopic intervention. [10] Radiologic imaging and endoscopic examination methods can be used in patients with suspected GIST. Upright abdominal X-ray may show a non-specific soft tissue shadow and rarely calcifications. In barium upper and lower gastrointestinal series, it can be seen as an enlargement within the lumen or submucosal mass, while exophytic growth may show external compression effect on the adjacent organ or intestinal segment. [11] In addition, in abdominal ultrasonography, CT and magnetic resonance imaging methods, it may present as lesions with exophytic spread, which may also show luminal growth, mostly originating from the wall of the digestive system. [12] In our case, CT showed a mass lesion with a soft tis- sue density of 67x33 mm in the widest portion, protruding into the lumen proximal to the ileal loops. In the upper or lower gastrointestinal endoscopy, it may be seen as a submucosal lesion, however, in endosonography, as a hypoechoic lesion originating from muscularis propria. [11] [18F] Fluorodeoxyglucose (FDG) positron emission tomography (PET) is not a specific but sensitive method in the diagnosis of GISTs. It can be used to evaluate the spread of the disease and to monitor the metabolic activity of the tumor. It is also a useful method for detecting distant metastases because it provides the possibility for the imaging of whole body. [11] GISTs can be diagnosed more frequently with immunohistochemical staining methods by the extracellular membrane protein CD34, the tyrosine kinase receptor CD117, known as KIT, and DOG1 protein. The underlying pathophysiology in terms of molecular carcinogenesis mechanisms is the excessive increase in the function of the tyrosine kinase receptor (KIT) in the cell membrane. In normal physiology, a monomeric tyrosine kinase receptor structure is present. When the extracellular ligand stem cell factor (SCF) binds to this receptor, dimerization occurs. [13] This dimerization then leads to autophosphorylation, activating intracellular signaling pathways, leading to increased cell proliferation. [14] KIT gene mutation is most commonly found in exon-11. In 10%-20% of GISTs, KIT mutation is seen in exon-9 and these tumors develop mostly in the small intestines. [15] Platelet-derived growth factor receptor-alpha (PDGFR-α) is another oncogene responsible for the activation of the intracellular phosphorylation cascade. PDGFR-α mutated GISTs are generally seen in KIT positive tumors. [16] In GISTs, CD117 is detected in 98%-100% of the cases. [2] In GISTs, CD34 is found to be 70%-80%, smooth muscle actin (SMA) 20%-40% and desmin 1%-2%, while S-100 is found to be 5% positive. [2, 6, 14, 17] In the immunohistochemical panel of our case, staining ratio was strongly diffuse positive for CD117 (c-KIT) and CD34, focal positive for SMA and negative for S-100.
The diameter and number of mitosis in GISTs are the two most common parameters used to determine the prognosis. Bucher et al. [18] described a useful staging system consists of 5 minor and 2 major criteria after surgical resection. Minor criteria are tumor size ≥5 cm, mitotic index ≥5, presence of necrosis, spread to surrounding tissue and MIB-1 (Ki-67) index >10%. The presence of lymph node invasion and the presence of metastasis constitute the major criteria. If the tumor consists of less than 4 minor criteria, it is classified as low grade GIST, if it has 4 or 5 minor criteria and 1 major criterion, it is classified as high grade GIST. In our case, the tumor diameter was 7.5 cm and the mitosis index was 10/50 high power fields. Malignant course is seen in 40% of the GISTs with small intestine origin and 20% of the GISTs with gastric origin. [19] Surgical resection is always the gold standard in the treatment of GISTs, with advances in medical oncologic therapies, and total excision is the most successful treatment modality today. A wide surgical margin and lymph node dissection are rarely required in GISTs. For this reason, laparoscopic surgery can generally be performed safely. [20] Patients who cannot have total resection due to distant metastases or locally advanced disease, and patients whose general condition is not suitable for surgery due to co-morbidities, or if surgical interventions with high morbidity and mortality are required; medical treatment might be preferred as a first line of therapy instead of surgery. There are three main objectives in GIST surgery; these are negative surgical margins, removal of the tumor without rupture, and complete resection of R0 without any visible tumor, respectively. [21] In histopathologically diagnosed patients with GIST, remission and regression of 50%-80% can be achieved with the use of imatinib mesylate, a tyrosine kinase inhibitor. [22] In addition, imatinib mesylate has been used extensively in the first-line treatment of unresectable, recurrent or metastatic GISTs. [11, 22, 23] 
Conclusion
As a result, total resection should be performed as much as possible in small intestine GISTs, which is a pathology present with nonspecific complaints and symptoms and usually requiring urgent surgical intervention. If it cannot be resected, a biopsy from this mass should be taken and sent to histopathological examination and medical treatment should be planned according to the result.
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